For instance, in non-small cell lung cancer (NSCLC), pterostilbene can decrease cell viability and induce apoptosis by activating endoplasmic reticulum stress signaling (Ma et al., 2017), while in ovarian cancer cells, pterostilbene can inhibit cell growth by inducing apoptosis and blocking cell cycle progression via inhibition of the STAT3 pathway (Wen et al., 2018). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.